| Literature DB >> 35418970 |
Xiao-Ping Peng1, Gang Li1, Li-Mei Wang1, Qi Wang1, Cong Wang2, Li-Xia Ji1, Chen-Xi Cao1, Guo-Feng Lin1, Zu-Yang Jiang1, Zhuo-Qian He1, Pei Wang3, Hong-Xiang Lou1,4.
Abstract
Three new sorbicillinoids, including trimer trisorbicillinone E (1), acremosorbicillinoids A and B (2 and 3), and a new alkaloid acremokaloid A (4), and a new natural product 2S,3S-acetyl-β-methyltryptophan (5), were isolated from an endophytic fungus Acremonium citrinum SS-g13, which is found in Fructus mori plant root. In addition, eight known sorbicillinoids (6-13) were also obtained. The new compound structures were established using NMR, HRESIMS spectra, and reported spectroscopic data. The absolute configurations of compounds 1-5, were determined by spectroscopic analysis, Snatzke's method, and time-dependent density functional theory-electronic circular dichroism (TDDFT-ECD) calculations. Compound 11 exhibited significant cholesterol efflux enhancing activity. A plausible biosynthesis pathway for the sorbicillinoids is discussed.Entities:
Keywords: Acremonium; Fructus mori; endophyte; sorbicillinoid; trisorbicillinoid
Year: 2022 PMID: 35418970 PMCID: PMC8997241 DOI: 10.3389/fmicb.2022.800626
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Structures of compounds 1–13.
1H NMR (500 MHz) and 13C NMR (125 MHz) data for 1 in CDCl3 (δ in ppm, J in Hz).
| Position | δC, type | δH, ( |
| 1 | 62.3, C | |
| 2 | 195.7, C | |
| 3 | 107.8, C | |
| 4 | 45.6, CH | 3.04, s |
| 5 | 75.8, C | |
| 6 | 211.4, C | |
| 7 | 50.6, CH | 2.75, m |
| 8 | 41.9, CH | 3.61, d (6.9) |
| 9 | 181.8, C | |
| 10 | 31.9, CH2 | 2.16, m |
| 11 | 28.5, CH2 | 2.28, m |
| 12 | 129.3, CH | 5.41, m |
| 13 | 126.8, CH | 5.50, m |
| 14 | 18.0, CH3 | 1.66 |
| 15 | 127.8, CH | 4.98, dd (14.6, 9.6) |
| 16 | 130.4, CH | 5.35, m |
| 17 | 17.7, CH3 | 1.59, d (6.3) |
| 18 | 190.6, C | |
| 1′ | 57.8, CH | 2.92, s |
| 2′ | 103.7, C | |
| 3′ | 195.1, C | |
| 4′ | 57.9, C | |
| 5′ | 103.9, C | |
| 6′ | 78.7, C | |
| 7′ | 57.9, CH | 3.00, s |
| 8′ | 104.3, C | |
| 9′ | 193.1, C | |
| 10′ | 57.6, C | |
| 11′ | 104.0, C | |
| 12′ | 78.8, C | |
| 13′ | 192.5, C | |
| 14′ | 34.7, CH2 | 2.43, m |
| 15′ | 28.5, CH2 | 2.28, m |
| 16′ | 129.1, CH | 5.41, m |
| 17′ | 126.7, CH | 5.49, m |
| 18′ | 18.0, CH3 | 1.64 |
| CH3-1 | 9.9, CH3 | 1.11, s |
| CH3-5 | 24.9, CH3 | 1.26, s |
| CH3-4′ | 19.0, CH3 | 1.42, s |
| CH3-6′ | 21.1, CH3 | 1.30, s |
| CH3-10′ | 18.2, CH3 | 1.52, s |
| CH3-12′ | 21.3, CH3 | 1.44, s |
1H NMR (500 MHz) and 13C NMR (125 MHz) data for 2 in DMSO-d6 (δ in ppm, J in Hz).
| Position | δC, type | δH, ( |
| 1 | 37.9, CH2 | 2.38, m; 2.33, m |
| 2 | 210.5, C | |
| 3 | 37.7, CH | 2.82, dt (6.9, 11.3) |
| 4 | 41.0, CH2 | 2.35, m; 2.05, m |
| 5 | 48.7, CH | 2.92, t (4.9) |
| 6 | 40.0, CH | 2.25, m |
| 7 | 83.3, C | |
| 8 | 131.6, C | |
| 9 | 81.0, C | |
| 10 | 177.6, C | |
| 11 | 22.0, CH3 | 1.06, s |
| 12 | 6.8, CH3 | 1.34, s |
| 13 | 131.6, CH | 5.22, dd (15.4, 7.3) |
| 14 | 125.3, CH | 5.31, m |
| 15 | 17.7, CH3 | 1.56, d (6.8) |
| 16 | 212.8, C | |
| 17 | 43.6, CH2 | 2.27, m |
| 18 | 25.8, CH2 | 2.04, m |
| 19 | 130.3, CH | 5.35, m |
| 20 | 124.7, CH | 5.35, m |
| 21 | 17.6, CH3 | 1.58, d (6.5) |
1H NMR (600 MHz) and 13C NMR (150 MHz) data for 3 in DMSO-d6 (δ in ppm, J in Hz).
| Position | δC, type | δH, ( |
| 1 | 111.5, C | |
| 2 | 164.0, C | |
| 3 | 101.9, CH | 6.29, s |
| 4 | 162.8, C | |
| 5 | 116.6, C | |
| 6 | 132.2, CH | 7.61, s |
| 7 | 204.9, C | |
| 8 | 34.0, CH2 | 3.03, m; 2.94, m |
| 9 | 28.2, CH2 | 1.89, m; 1.53, m |
| 10 | 74.2, CH | 3.21, m ddd (2.9, 8.9, 6.2) |
| 11 | 69.6, CH | 3.40, dq (6.2, 6.2) |
| 12 | 19.5, CH3 | 1.06, d (6.2) |
| 13 | 15.3, CH3 | 2.05, s |
1H NMR (500 MHz) and 13C NMR (125 MHz) data for 4 in DMSO-d6 (δ in ppm, J in Hz).
| Position | δC, type | δH, ( |
| 2 | 144.4, C | |
| 3 | 121.2, C | |
| 4 | 176.7, C | |
| 5 | 121.2, C | |
| 6 | 138.5, CH | 7.56, s |
| 7 | 55.0, CH2 | 3.88, t (5.5) |
| 8 | 60.1, CH2 | 3.56, m |
| 9 | 121.3, CH | 6.36, d (15.9) |
| 10 | 138.8, CH | 6.40, m |
| 11 | 130.9, CH | 6.29, dd (15.3, 7.4) |
| 12 | 133.2, CH | 5.94, m |
| 13 | 18.1, CH3 | 1.80, d (6.7) |
| 14 | 13.3, CH3 | 1.89, s |
| 15 | 13.8, CH3 | 1.84, s |
| 8-OH | 4.96, br s |
1H NMR (600 MHz) and 13C NMR (150 MHz) data for 5 in DMSO-d6 (δ in ppm, J in Hz).
| Position | δC, type | δH, ( |
| 1 | 173.6, C | |
| 2 | 57.2, CH | 4.57, dd (8.6, 6.0) |
| 3 | 32.3, CH | 3.57, m |
| 4 | 16.6, CH3 | 1.31, d (7.1) |
| 1′ | 10.80, s | |
| 2′ | 122.2, CH | 7.12, s |
| 3′ | 116.4, C | |
| 3a′ | 126.5, C | |
| 4′ | 118.4, CH | 7.54, d (7.9) |
| 5′ | 118.1, CH | 6.97, t (7.4) |
| 6′ | 120.7, CH | 7.05, t (7.5) |
| 7′ | 111.4, CH | 7.32, d (8.1) |
| 7a′ | 136.1, C | |
| 8′ | 169.2, C | |
| 9′ | 22.5, CH3 | 1.83, s |
| NH | 7.94, d (8.8) |
FIGURE 21H-1H COSY (blue bold lines), Key HMBC (red arrows) correlations of trisorbicillinone E (1).
FIGURE 3Key NOESY correlations of compound 1.
FIGURE 4Experimental and calculated ECD spectra of compound 1 (calcd. ECD curves with a bathochromic shift for 20 nm).
FIGURE 51H-1H COSY (blue bold lines), Key HMBC (red arrows) correlations of compounds 2-5.
FIGURE 6Key NOESY and 1D NOE correlations of compounds 2 and 4.
FIGURE 7Experimental and calculated ECD spectra of compound 2 (calcd. ECD curves with a bathochromic shift for 45 nm).
FIGURE 8Induced circular dichroism (ICD) spectra from the Mo2-complexe of 3 in DMSO.
FIGURE 9Experimental and calculated ECD spectra of compound 5.
SCHEMEPlausible Biosynthetic Pathways of Monomeric Sorbicillinoids (red shaded), Bisorbicillinoids (green shaded), Trisorbicillinoid (yellow shaded), and Hybrid Sorbicillinoid (blue shaded).